MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 146382 | Name: Bemesetron

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Bemesetron is a selective 5-HT3 receptor antagonist primarily used as an antiemetic to prevent and treat nausea and vomiting associated with chemotherapy, radiation therapy, and postoperative recovery. By blocking serotonin receptors in both the central nervous system and the gastrointestinal tract, it inhibits the emetogenic signals triggered by serotonin release. This mechanism makes it effective in controlling acute phases of emesis. Its action is similar to other 5-HT3 antagonists like ondansetron but may differ slightly in pharmacokinetics and receptor affinity.

Chemical Structure

Bemesetron
Bemesetron
CAS#40796-97-2

Theoretical Analysis

MedKoo Cat#: 146382

Name: Bemesetron

CAS#: 40796-97-2

Chemical Formula: C15H17Cl2NO2

Exact Mass: 313.0636

Molecular Weight: 314.21

Elemental Analysis: C, 57.34; H, 5.45; Cl, 22.56; N, 4.46; O, 10.18

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Bemesetron;
IUPAC/Chemical Name
(1R,3r,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3,5-dichlorobenzoate
InChi Key
MNJNPLVXBISNSX-WDNDVIMCSA-N
InChi Code
1S/C15H17Cl2NO2/c1-18-12-2-3-13(18)8-14(7-12)20-15(19)9-4-10(16)6-11(17)5-9/h4-6,12-14H,2-3,7-8H2,1H3/t12-,13+,14+
SMILES Code
CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C3=CC(Cl)=CC(Cl)=C3
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 314.21 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Arnold B, Allison K, Ivanová S, Paetsch PR, Paslawski T, Greenshaw AJ. 5HT3 receptor antagonists do not block nicotine induced hyperactivity in rats. Psychopharmacology (Berl). 1995 May;119(2):213-21. doi: 10.1007/BF02246163. PMID: 7659769. 2: Wang L, Cai S, Huang Z, Shao Q, Ma R, Zhai J. Serotonin receptor subtypes that depolarize guinea pig inferior mesenteric ganglion neurons. Brain Res. 1999 Aug 21;839(1):23-34. doi: 10.1016/s0006-8993(99)01632-7. PMID: 10482795. 3: Maksay G, Bíró T. Dual cooperative allosteric modulation of binding to ionotropic glycine receptors. Neuropharmacology. 2002 Dec;43(7):1087-98. doi: 10.1016/s0028-3908(02)00213-7. Erratum in: Neuropharmacology. 2003 May;44(6):843. PMID: 12504915. 4: Freeman AJ, Bountra C, Dale TJ, Gardner CJ, Twissell DJ. The vomiting reflex and the role of 5-HT3 receptors. Anticancer Drugs. 1993 Dec;4 Suppl 2:9-15. doi: 10.1097/00001813-199312002-00002. PMID: 7511008. 5: Silva SR, Futuro-Neto HA, Pires JG. Effects of 5-HT3 receptor antagonists on neuroleptic-induced catalepsy in mice. Neuropharmacology. 1995 Jan;34(1):97-9. doi: 10.1016/0028-3908(94)00146-j. PMID: 7623968. 6: Banner SE, Sanger GJ. Differences between 5-HT3 receptor antagonists in modulation of visceral hypersensitivity. Br J Pharmacol. 1995 Jan;114(2):558-62. doi: 10.1111/j.1476-5381.1995.tb13263.x. PMID: 7881756; PMCID: PMC1510257. 7: Wozniak KM, Linnoila M. Hyperglycemic properties of serotonin receptor antagonists. Life Sci. 1991;49(2):101-9. doi: 10.1016/0024-3205(91)90023-5. PMID: 1905770. 8: Peters JA, Malone HM, Lambert JJ. An electrophysiological investigation of the properties of 5-HT3 receptors of rabbit nodose ganglion neurones in culture. Br J Pharmacol. 1993 Oct;110(2):665-76. doi: 10.1111/j.1476-5381.1993.tb13863.x. PMID: 7694755; PMCID: PMC2175932. 9: Fozard JR. Neuronal 5-HT receptors in the periphery. Neuropharmacology. 1984 Dec;23(12B):1473-86. doi: 10.1016/0028-3908(84)90091-1. PMID: 6527747. 10: Morton RA, Baptista-Hon DT, Hales TG, Lovinger DM. Agonist- and antagonist- induced up-regulation of surface 5-HT3 A receptors. Br J Pharmacol. 2015 Aug;172(16):4066-77. doi: 10.1111/bph.13197. Epub 2015 Jul 6. PMID: 25989383; PMCID: PMC4543613. 11: Kim W, Kim MJ, Go D, Min BI, Na HS, Kim SK. Combined Effects of Bee Venom Acupuncture and Morphine on Oxaliplatin-Induced Neuropathic Pain in Mice. Toxins (Basel). 2016 Jan 22;8(2):33. doi: 10.3390/toxins8020033. PMID: 26805884; PMCID: PMC4773786. 12: Zhang X, Kan Q, Fu Y, Liu S, Dai Z, Dong Y. Noradrenergic activity regulated dexamethasone-induced increase of 5-HT₃ receptor-mediated glutamate release in the rat's prelimbic cortex. Biochim Biophys Acta. 2012 Dec;1823(12):2157-67. doi: 10.1016/j.bbamcr.2012.08.006. Epub 2012 Aug 20. PMID: 22940077. 13: Bartman ME, Wilkerson JE, Johnson SM. 5-HT3 receptor-dependent modulation of respiratory burst frequency, regularity, and episodicity in isolated adult turtle brainstems. Respir Physiol Neurobiol. 2010 Jun 30;172(1-2):42-52. doi: 10.1016/j.resp.2010.04.008. Epub 2010 Apr 23. PMID: 20399913; PMCID: PMC2905032. 14: Giordano J, Dyche J. Differential analgesic actions of serotonin 5-HT3 receptor antagonists in the mouse. Neuropharmacology. 1989 Apr;28(4):423-7. doi: 10.1016/0028-3908(89)90040-3. PMID: 2526302. 15: Meririnne E, Kajos M, Kankaanpää A, Seppälä T. Rewarding properties of 1-benzylpiperazine, a new drug of abuse, in rats. Basic Clin Pharmacol Toxicol. 2006 Apr;98(4):346-50. doi: 10.1111/j.1742-7843.2006.pto_243.x. PMID: 16623856. 16: Rudissaar R, Pruus K, Skrebuhhova T, Allikmets L, Matto V. Modulatory role of 5-HT3 receptors in mediation of apomorphine-induced aggressive behaviour in male rats. Behav Brain Res. 1999 Dec;106(1-2):91-6. doi: 10.1016/s0166-4328(99)00095-9. PMID: 10595424. 17: Monti JM, Ponzoni A, Jantos H, Lagos P, Silveira R, Banchero P. Effects of accumbens m-chlorophenylbiguanide microinjections on sleep and waking in intact and 6-hydroxydopamine-treated rats. Eur J Pharmacol. 1999 Jan 8;364(2-3):89-98. doi: 10.1016/s0014-2999(98)00826-7. PMID: 9932710. 18: Karlsson C, Bodelsson G, Bodelsson M, Stjernquist M. Characterization of 5-hydroxytryptamine receptors mediating circular smooth muscle contraction in the human umbilical artery. Gynecol Obstet Invest. 1999;47(2):102-7. doi: 10.1159/000010071. PMID: 9949279. 19: Jinka TR, Rasley BT, Drew KL. Inhibition of NMDA-type glutamate receptors induces arousal from torpor in hibernating arctic ground squirrels (Urocitellus parryii). J Neurochem. 2012 Sep;122(5):934-40. doi: 10.1111/j.1471-4159.2012.07832.x. Epub 2012 Jul 11. PMID: 22697356; PMCID: PMC3423511. 20: Kawai R, Kobayashi S, Fujito Y, Ito E. Multiple subtypes of serotonin receptors in the feeding circuit of a pond snail. Zoolog Sci. 2011 Jul;28(7):517-25. doi: 10.2108/zsj.28.517. PMID: 21728800.